DaVita HealthCare Partners Insider Sells $180,350 in Stock (DVA)
DaVita HealthCare Partners (NYSE:DVA) Insider Jeanine Marie Jiganti unloaded 2,500 shares of the company’s stock on the open market in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $72.14, for a total value of $180,350.00. Following the transaction, the insider now directly owns 3,526 shares in the company, valued at approximately $254,366. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on DVA. Analysts at Zacks reiterated a “neutral” rating on shares of DaVita HealthCare Partners in a research note on Friday, August 1st. They now have a $74.00 price target on the stock. Separately, analysts at Raymond James downgraded shares of DaVita HealthCare Partners from an “outperform” rating to a “market perform” rating in a research note on Monday, July 21st. They now have a $75.00 price target on the stock. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. DaVita HealthCare Partners presently has a consensus rating of “Buy” and an average target price of $75.33.
DaVita HealthCare Partners (NYSE:DVA) traded up 0.35% during mid-day trading on Tuesday, hitting $72.04. The stock had a trading volume of 608,446 shares. DaVita HealthCare Partners has a 52 week low of $52.75 and a 52 week high of $74.84. The stock’s 50-day moving average is $72.28 and its 200-day moving average is $69.29. The company has a market cap of $15.474 billion and a P/E ratio of 22.73.
DaVita HealthCare Partners (NYSE:DVA) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.95 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.89 by $0.06. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.10 billion. During the same quarter in the prior year, the company posted $1.84 earnings per share. The company’s quarterly revenue was up 10.5% on a year-over-year basis. On average, analysts predict that DaVita HealthCare Partners will post $3.63 earnings per share for the current fiscal year.
DaVita HealthCare Partners Inc, formerly DaVita Inc, is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (NYSE:DVA).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.